A COMPARAISON OF SOME PHARMACOLOGICAL EFFECTS OF ESCHERICHIA COLI (E. COLI) L-ASPARAGINASE AND E. COLI ENDOTOXIN IN RABBITSHERMAN EH; MHATRE RM; COONEY DA et al.1973; PHARMACOLOGY; SWITZ.; DA. 1973; VOL. 9; NO 2; PP. 85-96; BIBL. 15REF.Serial Issue

MODIFICATION OF SOME OF THE TOXIC EFFECTS OF DAUNOMYCIN (NSC-82,151) BY PRETREATEMENT WITH THE ANTINEOPLASIC AGENT ICRF 159 (NSC-129,943) = MODIFICATION DE QUELQUES EFFETS TOXIQUES DE LA DAUNOMYCINE (NSC-82 151) PAR LE TRAITEMENT PREALABLE PAR L'AGENT ANTINEOPLASIQUE ICRF 159 (NSC-129 443)HERMAN EH; MHATRE RM; CHADWICK DP et al.1974; TOXICOL. APPL. PHARMACOL.; U.S.A.; DA. 1974; VOL. 27; NO 3; PP. 517-526; BIBL. 13REF.Article

PHARMACOLOGIC DISPOSITION OF CHLOROZOTOCIN IN MICEMHATRE RM; PANASCI LC; FOX P et al.1978; CANCER TREATM. REP.; USA; DA. 1978; VOL. 62; NO 8; PP. 1145-1151; BIBL. 11 REF.Article